Active, Not Recruiting
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
NCT01861314
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, +8 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States